세계의 급성 췌장염 시장 규모, 점유율, 성장 분석 : 진단별, 원인별, 치료별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Acute Pancreatitis Market Size, Share, Growth Analysis, By Diagnosis (Imaging Tests, Laboratory Tests), By Cause (Gallstones, Alcohol), By Treatment, By End user, By Region - Industry Forecast 2025-2032
상품코드:1630773
리서치사:SkyQuest
발행일:2025년 01월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
급성 췌장염 세계 시장 규모는 2023년 58억 달러로 평가되었습니다. 또한, 예측 기간(2025-2032년) 동안 5.9%의 연평균 복합 성장률(CAGR)로 2024년 61억 4,000만 달러에서 2032년에는 97억 2,000만 달러로 성장할 것으로 예상됩니다.
세계 급성 췌장염 시장은 환자 수 증가와 의학의 눈부신 발전에 힘입어 빠르게 발전하고 있습니다. 심각한 췌장염은 심각한 건강 위험을 초래하기 때문에 효과적인 진단, 치료 및 관리 솔루션에 대한 수요가 증가하고 있습니다. 주요 시장 성장 촉진요인으로는 비만, 음주, 담석과 같은 위험 요인으로 인한 유병률 증가, 진단 기술의 발전, 새로운 치료 옵션 등이 있습니다. 이 분야는 경쟁이 치열하며, 제약사, 의료기기 제조업체 및 의료 서비스 제공업체들은 연구, 임상시험 및 전략적 제휴를 통해 제품을 개선하기 위해 적극적으로 노력하고 있습니다. 지속적인 혁신과 협업이 시장의 미래를 형성하고 환자 결과를 개선하고 이 중대한 건강 상태와 관련된 복잡성을 해결하기 위해 노력할 것으로 예상됩니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술 진보
급성 췌장염 시장 규모 : 진단별 & CAGR(2025-2032년)
시장 개요
영상 검사
임상 검사
급성 췌장염 시장 규모 : 원인별 & CAGR(2025-2032년)
시장 개요
담석
알코올
기타
급성 췌장염 시장 규모 : 치료별 & CAGR(2025-2032년)
시장 개요
점적
영양 보급
진통제
내시경적 역행성 담췌관 조영검사(ERCP)
기타
급성 췌장염 시장 규모 : 최종사용자별 & CAGR(2025-2032년)
시장 개요
병원
클리닉
진단센터
기타
급성 췌장염 시장 규모 : 지역별 & CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출 전년대비 비교(2022-2024)
주요 기업 개요
Pfizer Inc.(United States)
Merck & Co., Inc.(United States)
Baxter International Inc.(United States)
Abbott Laboratories(United States)
B. Braun SE(Germany)
CalciMedica Inc.(United States)
Dynavax Technologies Corporation(United States)
Fresenius SE & Co. KGaA(Germany)
GlaxoSmithKline plc(United Kingdom)
Olympus Corporation(Japan)
SCM Lifescience(South Korea)
Samsung Bioepis(South Korea)
GNT Pharma Co.(South Korea)
Medtronic plc(Ireland)
Boston Scientific Corporation(United States)
Takeda Pharmaceuticals(Japan)
Novartis AG(Switzerland)
AbbVie Inc.(United States)
General Electric Company(United States)
Mitsubishi Tanabe Pharma Corporation(Japan)
결론과 추천 사항
LSH
영문 목차
영문목차
Global Acute Pancreatitis Market size was valued at USD 5.8 billion in 2023 and is poised to grow from USD 6.14 billion in 2024 to USD 9.72 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2025-2032).
The global acute pancreatitis market is evolving rapidly, fueled by rising case numbers and significant medical advancements. This severe pancreatic inflammation poses serious health risks, resulting in a growing demand for effective diagnosis, treatment, and management solutions. Key market drivers include increased prevalence attributed to risk factors like obesity, alcohol consumption, and gallstones, alongside improvements in diagnostic technologies and novel therapeutic options. The sector is highly competitive, with pharmaceutical firms, medical device manufacturers, and healthcare providers actively engaged in research, clinical trials, and strategic alliances to enhance their offerings. Continuous innovation and collaboration are anticipated to shape the market's future, aiming to improve patient outcomes and address the complexities associated with this critical health condition.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Acute Pancreatitis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Acute Pancreatitis Market Segmental Analysis
Global Acute Pancreatitis Market is segmented by Diagnosis, Cause, Treatment, End user and region. Based on Diagnosis, the market is segmented into Imaging Tests and Laboratory Tests. Based on Cause, the market is segmented into Gallstones, Alcohol and Others. Based on Treatment, the market is segmented into Intravenous fluid, Nutritional support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP) and Others. Based on End user, the market is segmented into Hospitals, Clinics, Diagnostic Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Acute Pancreatitis Market
The Global Acute Pancreatitis market is expected to experience significant growth driven by the rising prevalence of diabetes, which can be exacerbated by pancreatitis as it damages insulin-producing cells in the pancreas. Approximately 45% of individuals with chronic pancreatitis eventually develop diabetes, highlighting a crucial link between these conditions. Furthermore, the market is supported by an aging population and proactive government initiatives aimed at enhancing awareness and education regarding pancreatic health. Additionally, changing consumer lifestyles, increasing obesity rates, and the potential rise in pancreatic cancer cases will further contribute to the expansion of the Acute Pancreatitis market.
Restraints in the Global Acute Pancreatitis Market
The Global Acute Pancreatitis market faces several significant restraints that may hinder its growth. One of the primary challenges is the high cost associated with treatment, which can limit accessibility for patients. Furthermore, developing economies may struggle with inadequate healthcare infrastructure, complicating treatment access and reducing market expansion potential. Additionally, a stringent regulatory environment adds another layer of complexity, while poor reimbursement practices deter patients from seeking necessary care. Lastly, a lack of public awareness about Acute Pancreatitis further stifles market growth, as it reduces the urgency for innovative treatments and interventions. These factors collectively contribute to a slow market development trajectory.
Market Trends of the Global Acute Pancreatitis Market
The global acute pancreatitis market is currently experiencing notable trends that emphasize early diagnosis and personalized treatment strategies. Increased investment in advanced diagnostic technologies aims to facilitate the swift identification of acute pancreatitis, allowing for timely therapeutic intervention and reduced complication rates. Furthermore, there is a rising inclination towards precision medicine, driven by advancements in genetic profiling and molecular diagnostics that allow for customized treatment plans. Additionally, the integration of digital health solutions is revolutionizing patient management and monitoring. Collectively, these trends are driving innovation in therapies, improving patient outcomes, and enhancing overall care in the acute pancreatitis landscape.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Global Acute Pancreatitis Market Size by Diagnosis & CAGR (2025-2032)
Market Overview
Imaging Tests
Laboratory Tests
Global Acute Pancreatitis Market Size by Cause & CAGR (2025-2032)
Market Overview
Gallstones
Alcohol
Others
Global Acute Pancreatitis Market Size by Treatment & CAGR (2025-2032)
